Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAC-24: Oral Tranexamic Acid Post-op in Hip and Knee Arthroplasty
NCT03690037Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in hemorrhage (3 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Total Indirect blood loss at 48 hours. Started Jul 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03690037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03690037.